Iontas Ltd

Curie.Bio launched on 14 February with $520m to provide $5m-$7m in seed financing per start-up, plus access to in-house expertise and external research services, to help new biopharmas generate enough

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis

IN VITRO DIAGNOSTICS Alliances Angle PLC Qiagen NV Angle PLC and Qiagen NV will co-promote each other’s liquid biopsy solutions for cancer detection. (Sep.) To the deal Angle contributes its

Continuing a collaborative research agreement signed in 2016, Neon Therapeutics licensed technology from the [Netherlands Cancer Institute] (NKI) that will enable it to advance its personalized